• Home
    • History
    • Educational Endowment Fund
    • Distinguished Achievement Award
    • Board and Committees
    • The NEOS Logo
  • Public Information
  • Meetings
    • General Information
    • Upcoming Physician Meeting
    • Ophthalmic Medical Personnel Meeting
    • Ophthalmic Administrators Meeting
    • Future Meeting Registration & Submission
    • NEOS Exhibitors
    • Past Meeting Abstracts & Videos
  • Become a Member
  • Members
  • Exhibitors
    • Invitation 2019-2020
    • 2019-2020 Online Registration
    • 2019-2020 PDF Registration form
  • Donate

September 11, 2015 Conference

Back to the Future: The NEW and OLD in Glaucoma

Visual field Interpretation: How is the test? Is it worse?
Angela Turalba

Gonioscopy: Still “State of the Art” 100 Years After Salzmann’s First Look
M. Wallace Alward

Molecular Genetics of Glaucoma: So What?
M. Wallace Alward

Glaucoma Medical Treatment- tailoring treatment to the patient's needs
Paul Cotran

Assessing Progression in Glaucoma
Michael Koval

Glaucoma Surgery: Which Procedure, When, and Why
Babak Eliassi-Rad

Glaucoma Risk Assessment
Susan Liang

Glaucoma Technology Update: OCT and the Pipeline for Glaucoma Devices
Teresa C. Chen

Pharmacology

Anti-Inflammatory Pharmacology
Shiyoung Roh

Pharmacology of Glues and Sealants
Michael B. Raizman

Targeting conventional outflow: Disease modifying glaucoma therapeutics
Dan Stamer

Drug Delivery – Glaucoma Treatment in Development
Steve Simmons

Formulation and Preservatives in Eye Drops
Michael Pokabla

Pharmacology of Ocular Surface Disease Therapy
Helen K. Wu

Pharmacology of anti-infective therapy
Jessica Chow

Pharmacology of current glaucoma therapy
Kimberly Miller

 
New England Ophthalmological Society, Inc. PO Box 6305, Boston, MA 02114 - neosjudy@aol.com - www.neos-eyes.org

Conference Management Software by X-CD Technologies Inc.

Conference Management Software by X-CD Technologies Inc.

Tech Support